PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lorenzo GD et al. – In past years, there have been considerable advances in the understanding of renal cell carcinoma (RCC) biology. These advances have been translated into the development of several drugs with improved efficacy. Uro–oncologists today have a plethora of treatment options for metastatic RCC patients. Our knowledge will continue to evolve as new data become available, and we hope that knowledge translates to increased efficacy for patients.

   

Today in Hematology/Oncology...keeping you current

Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09

Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
JACC - Journal of the American College of Cardiology, 12/04/09

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09

Today in Nephrology...keeping you current

Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09

Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis
Nephrology Dialysis Transplantation, 12/04/09

External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address